newsfilter
← Latest News
PR Newswire·

Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS),...